Internal Medicine, Cardiovascular Disease · Vero Beach, FL
NPI
1972543486
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
960 37th Pl, Suite 105
Vero Beach, FL, 32960
Phone (772) 299-1901
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
20,311 services
Medicare patients, 2024
1,998
Average age 79
Drug cost, 2024
$4.0M
18,303 prescriptions
Company payments, 2025
$1,989
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Howard T Tee was code J0153 (injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)), 6,360 times for 106 patients. In total Howard T Tee billed 20,311 services in 83 codes, and Medicare paid $1.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-12-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 6,360 | 106 | $0.41 | $2,628 |
| 99214 Office E&M - Established | Office | 4,433 | 1,826 | $95.94 | $425K |
| 93000 Electrocardiogram | Office | 1,221 | 1,089 | $11.13 | $14K |
| 93306 Echocardiography (TTE/TEE) | Office | 919 | 898 | $150.93 | $139K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 801 | 137 | $50.24 | $40K |
| 93296 External Electrocardiographic Monitoring | Office | 691 | 231 | $15.77 | $11K |
| 93294 External Electrocardiographic Monitoring | Office | 625 | 210 | $21.98 | $14K |
| 93298 External Electrocardiographic Monitoring | Office | 390 | 48 | $79.83 | $31K |
| 99204 Office E&M - New | Office | 389 | 389 | $126.86 | $49K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 370 | 185 | $161.82 | $60K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 344 | 86 | $2.32 | $797 |
| 93356 Echocardiography (TTE/TEE) | Office | 341 | 337 | $29.38 | $10K |
| 99233 Hospital E&M - Subsequent | Facility | 301 | 112 | $98.14 | $30K |
| 93015 Electrocardiogram | Office | 279 | 278 | $51.41 | $14K |
| 93228 Electrocardiogram | Office | 215 | 213 | $19.73 | $4,242 |
By year: 2022 $1.1M for 12,101 services; 2023 $1.2M for 17,847 services; 2024 $1.5M for 20,311 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 26 | 11 | $4.24 | $110 |
Medicare prescription drug claims, 2024
In 2024, the drug Howard T Tee prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,405 prescriptions and refills. In total Howard T Tee wrote 18,303 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,405 | 2,810 | 349 | $1.6M |
| Metoprolol Succinate Generic | 1,110 | 3,020 | 337 | $17K |
| Atorvastatin Calcium Generic | 964 | 2,646 | 295 | $11K |
| Rosuvastatin Calcium Generic | 898 | 2,383 | 288 | $13K |
| Amlodipine Besylate Generic | 885 | 2,455 | 276 | $7,245 |
| Metoprolol Tartrate Generic | 693 | 1,930 | 227 | $6,723 |
| Losartan Potassium Generic | 560 | 1,567 | 184 | $5,904 |
| Sotalol Sotalol Hcl | 543 | 1,491 | 156 | $14K |
| Xarelto Rivaroxaban | 530 | 1,110 | 131 | $603K |
| Furosemide Generic | 515 | 1,228 | 182 | $3,143 |
| Carvedilol Generic | 469 | 1,269 | 146 | $4,249 |
| Lisinopril Generic | 427 | 1,203 | 135 | $4,065 |
| Ezetimibe Generic | 416 | 1,086 | 134 | $8,736 |
| Valsartan Generic | 345 | 933 | 110 | $11K |
| Hydrochlorothiazide Generic | 315 | 874 | 96 | $1,553 |
Brand drugs: 3,677 claims; generic drugs: 14,626 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Howard T Tee $1,989 ($1,989 in general payments such as food, travel and fees) from 22 companies. The largest payer was Novo Nordisk Inc with $210.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 8 | $210 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $207 |
| Merck Sharp & Dohme LLC MRK | 11 | $202 |
| Pfizer Inc. PFE | 9 | $197 |
| Abbott Laboratories ABT | 6 | $170 |
| Alnylam Pharmaceuticals Inc. ALNY | 3 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $102 |
| Kestra Medical Technology Services, Inc. | 3 | $96.19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92.11 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $90.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.